We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
According to local press reports, the Israeli health ministry
has granted marketing authorisation for local generics major Teva's Parkinson's
disease drug Azilect.
According to data recently released by IMS Health, retail pharmacy drug sales
in three leading Latin American markets grew by an average 13% in the year to
October 2004.
Morena Vista Trading has filed suit against Kinetana International BioTech Pharma in the California State Superior Court seeking damages of $6 million for intentional misrepresentation, breach of contract, civil racketeering and corrupt organization claims. Read More
According to reports, Switzerland-based pharmaceuticals producer Novartis has
received US FDA approval for Enablex extended-release tablets (7.5 mg and 15
mg), for the treatment of overactive bladder (OAB) with symptoms including urge
incontinence.
Following the introduction of India's new World Trade Organisation-compliant
framework for intellectual property on Jan. 1, industry reaction has been mixed
on the expected effectiveness of the legislation.
The profits of China's 23 key state-owned pharmaceutical
enterprises fell in the first 11 months of the year due to a large increase
in production costs coupled with a market-driven decline in the prices of some
medicines.
The Technion Israel Institute of Technology claims to have developed
an antibiotic agent capable of attacking anthrax bacteria at the same time as
tackling the toxic proteins released by the bacteria into an infected person's
bloodstream.
Swiss drug manufacturer Serono has announced that it will open a research and
development (R&D) facility in Israel through its subsidiary InterPharm,
in order to study aspects of genetic engineering.
Fifteen Ethiopian pharmaceutical companies and manufacturers
of medical supplies have announced the establishment of the Ethiopian Pharmaceutical
and Medical Supplies Manufacturers Sector Association.
UK-based drug manufacturer GlaxoSmithKline (GSK) is set
to become the first pharmaceutical firm to bypass the US FDA with the launch
of a vaccine against rotavirus in Mexico, which does not have FDA approval.